KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Dividends payables: 2010-2011

  • TherapeuticsMD's Dividends payables was N/A to $41,359 in Q3 2011 from the same period last year, while for Sep 2011 it was $41,359, marking a year-over-year change of. This contributed to the annual value of $41,359 for FY2010, which is N/A change from last year.
  • Per TherapeuticsMD's latest filing, its Dividends payables stood at $41,359 for Q3 2011, which was down 0.00% from $41,359 recorded in Q2 2011.
  • Over the past 5 years, TherapeuticsMD's Dividends payables peaked at $41,359 during Q4 2010, and registered a low of $41,359 during Q4 2010.
  • Over the past 2 years, TherapeuticsMD's median Dividends payables value was $41,359 (recorded in 2011), while the average stood at $41,359.